Kuehn Law Encourages Investors of Celularity Inc. to Contact Law Firm
March 22, 2024 13:24 ET
|
KUEHN LAW, PLLC
Kuehn Law investigates potential breach of fiduciary duties by Celularity officers and directors. Shareholders urged to contact for details.
SANUWAVE Health Completes Acquisition of the Wound Care Assets of Celularity
August 10, 2020 09:00 ET
|
SANUWAVE Health, Inc.
Conference Call Scheduled for Wednesday 1:00 p.m. EDT SUWANEE, GA, Aug. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- SANUWAVE Health, Inc. (OTCQB: SNWV) today announced that it has...
SORRENTO TO PROVIDE MANUFACTURING SUPPORT TO CELULARITY AS CYNK-001 NK CELL TRIAL FOR COVID-19 BEGINS ENROLLING PATIENTS
April 02, 2020 12:33 ET
|
Sorrento Therapeutics, Inc.
SAN DIEGO, April 02, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") announced it has initiated the next phase of its collaboration with Celularity, Inc., a Warren,...
Sorrento and Celularity to Initiate Emergency Allogeneic Natural Killer (NK) Cell Therapy Development for Coronavirus Infection
January 29, 2020 07:00 ET
|
Sorrento Therapeutics, Inc.
SAN DIEGO and WARREN, N.J., Jan. 29, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") announced it has initated a clinical and manufacturing collaboration with...